The Adhesion Barriers Market To Be Accelerated By Technology And Reach US$ 3,592.1 Mn

Adhesion barriers or anti-adhesions are medical implants, used post-surgeries to reduce or prevent internal adhesion (scarring) by separating tissue and organs, resulting in faster recovery. Available in gel, film, and liquid formulations, the sterile, transparent and highly viscous gels and collagen and gelatin-laden film-based adhesion barriers are highly preferred in all forms of surgery.

Growing number of patients opting for surgeries as a preferred treatment option (mostly used in cardiovascular surgeries), increasing geriatric population and corresponding health-related issues, and increasing awareness about severe post-surgery complications like adhesion formation, are some factors projected to drive the global adoption of adhesion barriers over the forecast period of 2018-2026.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/3202

Company Profiles

  • Baxter
  • Johnson & Johnson (Ethicon Inc.)
  • Anika Therapeutics, Inc.
  • Sanofi
  • FzioMed, Inc.
  • Betatech Medical
  • Integra LifeSciences Corporation
  • Tissuemed Ltd.
  • Hangzhou Singclean Medical Products Co., Ltd.
  • Symatese

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/3202

As per a recent market analysis by Persistence Market Research, the global adhesion barriers market is expected to expand at a robust 6.9% CAGR over the forecast period, with a market valuation of US$ 3,592.1 Mn by 2026. With clear market domination through 2017, North America adhesion barriers market is expected to represent highest incremental opportunity through 2026 too, attributable to product innovation and entry of new players.

Moreover, increasing number of cardiovascular interventions, such as coronary revascularization and coronary artery bypass graft surgery (CABG), is expected to drive the global adhesion barriers market from 2018 to 2026.

Procedures including laparoscopy and laparotomy predominantly gives rise to internal scarring. Owing to advancements in medical procedures and significant investments in the healthcare industry coupled with increasing awareness among the patients, Asia-Pacific is likely to be a fast growing region for adhesion barriers. Considering growth prospects in emerging markets, companies like Sanofi, Anika Therapeutics, and Baxter are competing to capture the maximum share in these markets.

Key players in the highly fragmented, oligopolistic global adhesion barriers market includes Baxter, Johnson & Johnson (Ethicon Inc.), Anika Therapeutics, Inc., Sanofi, FzioMed, Inc., Betatech Medical, Integra LifeSciences Corporation, Tissuemed Ltd., Hangzhou Singclean Medical Products Co., Ltd., and Symatese.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/3202

Companies are foreseen to capitalize on the growth potentiality of adhesion barriers market by focusing on acquisitions and partnerships to expand business presence and distributor network coupled with product portfolio build-up. Manufacturers are also entering into direct supply agreements with hospitals to increase product penetration and sales.